Biotech

VIKYNG AI Polypeptoids : the anti-infective revolution Biotech Prototyping, preclinical France Status Approved IP Type Patent Time 17 years Countries...

Generare Accessing the untapped therapeutics crafted by 450 million years of evolution Biotech Prototyping, preclinical France 3.200.000€ Status Pending IP...

Apmonia Therapeutics Disrupting the tumor stroma by targeting the extracellular matrix (ECM) Biotech Prototyping, preclinical France 1.000.000€ Status Approved IP...

Microviable Therapeutics SL Developing novel biological drugs based on the microbiome to treat infectious diseases and oncology Biotech Prototyping, preclinical...

Perha Pharmaceuticals Optimizing and developing innovative small molecules to address high unmet needs Biotech Development, market readiness, clinical trial France...

BioSmartData Cloud based platform for real-world research. Biotech Development, market readiness, clinical trial Spain 1.000.000€ You can visit their website...

ITRACSSOS SEPSIS BREAKTHROUGH MANAGEMENT Biotech Prototyping, preclinical FRANCE 1.500.000€ Status Approved IP Type Patent Time 13 years Countries USA Coverage...

QUIDDITAS S.A. Quidditas developed a novel genome editing platform which permits an absolute genetic recombination Biotech In vitro, proof of...

Mermaid Bio GmbH Pioneering intrabody medicines to give patients new hope. Biotech Prototyping, preclinical Germany 2.000.000€ Status Provisional IP Type...

VIVA IN VITRO DIAGNOSTICS, S.L. International biomed leader in NLRP3-based solutions Biotech In vitro, proof of concept SPAIN 2.500.000€ Status...